Identification of cathepsin B as a novel target of hypoxia-inducible factor-1-alpha in HepG2 cells

Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly unders...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 503; no. 2; pp. 1057 - 1062
Main Authors Xiaofei, Cheng, Yanqing, Li, Dongkai, Zhou, Dong, Chen, Feng, Zhao, Weilin, Wang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 05.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly understood. Our experimental results had shown that nuclear HIF-1α proteins were significantly induced after HepG2 cells treatment with 1% O2 for 6 h and reached the peak expression level in 24 h. Meanwhile, the results of RT-qPCR and Western-blotting showed that HIF-1α and cathepsin B (CTSB) expressions increased with a similar pattern in response to hypoxia in the HepG2 cells. Additionally, based on bioinformatics analysis, we identified a hypoxia response element in the CTSB promoter, indicating a possible association between HIF-1α and CTSB. Moreover, luciferase assay was performed to reflect the transcriptional activity mediated through the HIF-1α binding HRE within the CTSB promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) revealed a specific HIF-1α binding activity to the CTSB gene promoter. For the first time, we demonstrated that CTSB is a new HIF-1α-target gene. We believe these findings will contribute to the research and development of neoplasm-targeted therapies. •Cathepsin B (CTSB) is a novel target gene of hypoxia-inducible factor-1-alpha (HIF-1α).•CTSB mRNA and protein levels can be up-regulated in a HIF-1α-dependent manner.•CTSB promoter activity can be elevated by the HIF-1α protein.•HIF-1α protein binds the CTSB promoter directly.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2018.06.116